Psychedelics Biotech Co. Leaps Forward with Big Pharma Investment
Could 2022 be the year that psychedelic stocks break out? It might be too early to tell because public psychedelic companies are few and far between, but the industry is poised to reach considerable growth between now and 2027. Valued at approximately US$3.8 billion in 2020, the psychedelics drug market is expected to reach $10.76 billion by 2027. Stockhouse's Jocelyn Aspa reports.
Weekly Update - Top Cannabis News Stories
1 | Top Story: Xebra Brands commences trading on OTCQB.
2 | Delta 9 Cannabis Inc. provides guidance & timing for Q4 2021 results.
3 | Sugarbud Craft Growers Corp. announces timing of AGM.
4 | Trulieve Cannabis Corp. announces grand opening of affiliate's Philadelphia dispensary
5 | Pure Extracts Technologies Corp. signs white label agreement.
Top Cannabis Stocks | Jan 6 to Jan 12, 2022
1. TLRY | 45,057 views | Tilray Inc.
2. T.HEXO |37,144 views | HEXO Corp.
3. T.WEED | 17,758 views | Canopy Growth Corporation.
4. T.AH | 17,445 views | Aleafia Health Inc.
5. C.TNY | 8,424 views | Tinley Beverage Co Inc.
6. V.LFST | 7,313 views | Lifeist Wellness Inc.
FULL DISCLOSURE: Mindset Pharma Inc., Xebra Brands Ltd., Delta 9 Cannabis Inc., and Sugarbud Craft Growers Corp.are clients of Stockhouse Publishing.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub. Or, for lively sector discussion, visit Stockhouse’s new Cannabis Bullboards page.